Bristol-Myers Squibb reaps biologics in ZymoGenetics windfall.
Emma
E
Dorey
D001688:Biological Products / Q000191:economics*; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000191:economics; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D010330:Patents as Topic; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products